How is PT-141 classified?
A melanocortin receptor agonist with a receptor profile weighted toward MC3R and MC4R. This shift in selectivity relative to Melanotan II is the defining classification point in the literature.
How is its mechanism studied?
- MC4R signalling in central nervous system models.
- Neural pathway activation studied with imaging and behavioural endpoints in animals.
- Receptor-binding panels used to establish subtype preference.
What kind of research exists?
Unusually for a peptide in this library, PT-141 has a published randomised-trial record in addition to receptor pharmacology and animal work — a result of its development programme.
What is it studied alongside?
Melanotan II and α-MSH, and in central-receptor reviews alongside other MC4R-targeting compounds.
How does Neo Labs supply and handle it?
Lyophilised powder, sealed vial, batch COA. Cold, dark storage.